Sumathi Nambiar
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 11
- Drug-Induced Adverse Reactions 3
- Co-authors
- Nalini SinghJohn S. BradleyJohn FarleyLucia LeeDaniel B. RubinPeter W. KimLoreen A. HerwaldtEdward Cox
- Journals
- Clinical Infectious Diseases (11 papers)Clinical Pharmacology & Therapeutics (3 papers)PEDIATRICS (3 papers)The Pediatric Infectious Disease Journal (3 papers)Emerging infectious diseases (2 papers)
- Partner nations
- United StatesJapanIndia
In The Last Decade
Sumathi Nambiar
36 papers receiving 875 citations
Peers
Comparison fields: 5 of 100
- Applied Microbiology and Biotechnology 97
- Molecular Medicine 181
- Critical Care and Intensive Care Medicine 75
- Clinical Biochemistry 98
- Pharmacology 241
Countries citing papers authored by Sumathi Nambiar
This map shows the geographic impact of Sumathi Nambiar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumathi Nambiar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumathi Nambiar more than expected).
Fields of papers citing papers by Sumathi Nambiar
This network shows the impact of papers produced by Sumathi Nambiar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumathi Nambiar. The network helps show where Sumathi Nambiar may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumathi Nambiar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 33 | |
| 3 | 2018 | 5 | |
| 4 | 2018 | 6 | |
| 5 | 2017 | 14 | |
| 6 | 2015 | 56 | |
| 7 | 2014 | 43 | |
| 8 | 2014 | 16 | |
| 9 | 2013 | 7 | |
| 10 | 2012 | 58 | |
| 11 | 2012 | 61 | |
| 12 | 2010 | 52 | |
| 13 | 2010 | 3 | |
| 14 | 2008 | 23 | |
| 15 | 2005 | 2 | |
| 16 | 2005 | 28 | |
| 17 | 2003 | 40 | |
| 18 | 2002 | 74 | |
| 19 | 2002 | 9 | |
| 20 | 2001 | 4 |
About Sumathi Nambiar
Sumathi Nambiar is a scholar working on Applied Microbiology and Biotechnology, Pharmacology, Molecular Medicine, Infectious Diseases and Anesthesiology and Pain Medicine, having authored 37 papers that have together received 911 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Pharmaceutical studies and practices (9 papers), Pneumonia and Respiratory Infections (6 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Neonatal and Maternal Infections (4 papers), Pharmaceutical Economics and Policy (4 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (97 citations), Molecular Medicine (181 citations), Critical Care and Intensive Care Medicine (75 citations), Clinical Biochemistry (98 citations) and Pharmacology (241 citations). Sumathi Nambiar has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Nalini Singh, John S. Bradley, John Farley, Lucia Lee, Daniel B. Rubin, Peter W. Kim, Loreen A. Herwaldt, Edward Cox, Thamban Valappil and John Alexander. Their work appears in journals such as Clinical Infectious Diseases, Clinical Pharmacology & Therapeutics, PEDIATRICS, The Pediatric Infectious Disease Journal and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.